The company added that the device will be indicated for both paroxysmal and persistent atrial fibrillation. Citing data from its PULSED AF study, Medtronic (MDT) said that the PulseSelect PFA ...
Varipulse devices developed by Johnson & Johnson MedTech (NYSE:JNJ) have been approved by the U.S. Food and Drug Administration for treating paroxysmal atrial fibrillation in individuals not ...
marks a significant milestone in the clinical validation of AuriGen's novel "Zenith" LAAO device. Atrial fibrillation ("AF") affects over 60 million people worldwide and significantly increases ...
Medical device makers such as Boston Scientific and Medtronic also have devices approved for atrial fibrillation, a condition that is characterized by an irregular rhythm of the heart. The health ...
The odds of complications and early mortality are higher among LAAO recipients with kidney impairment. Chronic kidney disease (CKD) and end-stage kidney disease (ESKD) increase the risks for ...
Occluder to treat people with atrial fibrillation (AFib) who are at an increased risk of stroke. The new five-year findings demonstrate that Abbott's Amplatzer Amulet helps more patients avoid ...